![Marco Verwijs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marco Verwijs currently works at CervoMed, Inc., as Executive Vice President-Technical Operations from 2025.
Dr. Verwijs also formerly worked at Jade Biosciences, Inc., as Chief Technology Officer, Adipo Therapeutics LLC, as Chief Technical Officer, and Jade Biosciences, Inc., as Chief Technical Officer.
Dr. Verwijs received his doctorate degree from the University of Florida and graduate degree from Delft University of Technology.
| Unternehmen | Position | Beginn |
|---|---|---|
| CERVOMED INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
| JADE BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2024 |
| JADE BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Adipo Therapeutics LLC
 Adipo Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops polymer-based, notch-inhibiting nanoparticles that are injected directly into adipose (fat) tissue | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 5 |
|---|---|
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Delft University of Technology
 Delft University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Adipo Therapeutics LLC
Adipo Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops polymer-based, notch-inhibiting nanoparticles that are injected directly into adipose (fat) tissue | Health Technology |
CervoMed, Inc.
 CervoMed, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops novel therapies | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
